A perspective toward mass spectrometry-based de novo sequencing of endogenous antibodies.

ABSTRACT: A key step in therapeutic and endogenous humoral antibody characterization is identifying the amino acid sequence. So far, this task has been mainly tackled through sequencing of B-cell receptor (BCR) repertoires at the nucleotide level. Mass spectrometry (MS) has emerged as an alternative tool for obtaining sequence information directly at the - most relevant - protein level. Although several MS methods are now well established, analysis of recombinant and endogenous antibodies comes with a specific set of challenges, requiring approaches beyond the conventional proteomics workflows. Here, we review the challenges in MS-based sequencing of both recombinant as well as endogenous humoral antibodies and outline state-of-the-art methods attempting to overcome these obstacles. We highlight rec

SUBMITTER: de Graaf SC 

PROVIDER: S-EPMC9225641 | biostudies-literature | 2022 Jan-Dec

REPOSITORIES: biostudies-literature